Cargando…
S74. EXPLORING PARTICIPANT-LEVEL TRAJECTORIES OF COGNITIVE PERFORMANCE AMONG PATIENTS WITH SCHIZOPHRENIA IN A MULTI-NATIONAL TRIAL
BACKGROUND: It remains unclear whether the lack of clinical trial success and drug approval for cognitive impairment associated with schizophrenia (CIAS) is due to compounds being ineffective, or whether trial methodology itself has been a limiting factor in successfully demonstrating the efficacy o...
Autores principales: | Granger, Kiri, Cotter, Jack, Baker, Elizabeth, Evenden, John, Barnett, Jennifer, Sand, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887555/ http://dx.doi.org/10.1093/schbul/sby018.861 |
Ejemplares similares
-
F74. CLINICAL SYMPTOMS AND NOT OBJECTIVE COGNITIVE PERFORMANCE DRIVE SUBJECTIVE COGNITIVE COMPLAINTS IN PATIENTS WITH SCHIZOPHRENIA
por: Cotter, Jack, et al.
Publicado: (2018) -
The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia
por: Cotter, Jack, et al.
Publicado: (2019) -
T79. AFFECTIVE FACE PROCESSING IN SCHIZOPHRENIA: DISORDER-SPECIFIC OR TRANSDIAGNOSTIC DEFICIT?
por: Cotter, Jack, et al.
Publicado: (2018) -
T74. ACADEMIC ACHIEVEMENT AND SCHIZOPHRENIA: A META-ANALYSIS
por: Dickson, Hannah, et al.
Publicado: (2018) -
Using Affective Cognition to Enhance Precision Psychiatry
por: Cotter, Jack, et al.
Publicado: (2018)